Role of lysophosphatidylcholine (LPC) in atherosclerosis.
about
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancersThe clearance of dying cells: table for twoConsiderations for the Optimization of Induced White Matter Injury Preclinical ModelsStructural basis of transport of lysophospholipids by human serum albuminPrehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA2 activity, and oxidative stress.Nitro-oleic acid downregulates lipoprotein-associated phospholipase A2 expression via the p42/p44 MAPK and NFκB pathwaysLp-PLA2 Inhibition-The Atherosclerosis Panacea?Association between dairy intake, lipids and vascular structure and function in diabetesMatrix-assisted laser desorption ionization imaging mass spectrometry in lipidomics.Effects of chlorogenic acid on intracellular calcium regulation in lysophosphatidylcholine-treated endothelial cellsOxidized LDL: diversity, patterns of recognition, and pathophysiology.Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.Lysophosphatidic acid in atherosclerotic diseasesLysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapyDifferential Aortic and Mitral Valve Interstitial Cell Mineralization and the Induction of Mineralization by Lysophosphatidylcholine In Vitro.Altered plasma lysophosphatidylcholines and amides in non-obese and non-diabetic subjects with borderline-to-moderate hypertriglyceridemia: a case-control study.The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA.The role of uridine adenosine tetraphosphate in the vascular system.Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk.Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing.Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NFκB pathways.The protective effect of yi shen juan bi pill in arthritic rats with castration-induced kidney deficiency.Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age.Replacing carbohydrate with protein and fat in prediabetes or type-2 diabetes: greater effect on metabolites in PBMC than plasmaLysophosphatidylcholine, oxidized low-density lipoprotein and cardiovascular disease in Korean hemodialysis patients: analysis at 5 years of follow-upIntegrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease.Metabolic Profiles Distinguish Non-Dampness-Phlegm and Dampness-Phlegm Patterns among Korean Patients with Acute Cerebral Infarction.Differential lipid metabolism in monocytes and macrophages: influence of cholesterol loadingEffect of quercetin and its metabolite on caveolin-1 expression induced by oxidized LDL and lysophosphatidylcholine in endothelial cellsAssociation of age-related changes in circulating intermediary lipid metabolites, inflammatory and oxidative stress markers, and arterial stiffness in middle-aged men.Alcohol-induced metabolomic differences in humans.Distinct urinary lipid profile in children with focal segmental glomerulosclerosisG2A and LPC: regulatory functions in immunity.Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic miceChlorinated Phospholipids and Fatty Acids: (Patho)physiological Relevance, Potential Toxicity, and Analysis of Lipid ChlorohydrinsTRPC1/TRPC3 channels mediate lysophosphatidylcholine-induced apoptosis in cultured human coronary artery smooth muscles cells.
P2860
Q21198861-3A81E879-1D2B-42AB-917B-264B42EAE23DQ26753825-1BB10995-C5B5-4EC7-B677-B066C5FEFA0FQ26796210-CF5AC4BD-E6D1-4135-B196-1F9209595BFEQ27656406-D8533B42-6BE3-45AB-B00E-A9F93CD1E9CFQ33572961-183BF40E-916D-4B7D-90F9-7FB08328A8ECQ33585468-D9C79E6A-B392-4195-96F8-BEC708310656Q33664272-0857AD8B-3B46-4C70-9015-3A565B286A5CQ33706757-D74E38B1-505B-418F-A8D8-98195BBD99D8Q33817037-3848B8B2-571C-4FDD-8A98-BE80D586D624Q33874501-15C861F7-5813-4277-B8FE-5A26C2946D6DQ33879138-801D81BE-8C3F-43DF-AF64-52755A0A1F49Q34167926-3E9385E3-4FAC-4C09-923C-376603F3AF07Q34273486-6BFDF2EA-DD13-4EF5-9980-3CE2C4FFE9AEQ34393410-E52E22A6-35A2-4D7B-B999-76A118F26738Q34518525-D515F1F9-CBF3-47C7-B1E7-71D800B23024Q34534890-2CB1FA7E-BEF0-480F-939E-FE81C463239BQ35346739-257C1B5B-5B31-4069-BF6C-E249D3673157Q35395358-E063B730-A267-4105-AB45-5841CC1282C9Q35504071-6100B6C1-485A-4A60-BAA8-86188DDD2EF6Q35536385-A1B194FE-5C46-4B97-B197-1CF5F150C131Q35579609-2AD4A668-73F8-4A4B-ADBF-0E081C431ECEQ35616605-B25F1549-A445-42EB-AFCB-9395589D7647Q35896416-6AD72795-4804-4CE3-A548-E53EF10D08DDQ35931824-63164876-A5F0-4011-B3F0-5B412F96CB01Q36145180-43B511B6-12AD-4829-87BE-FB44ECB58837Q36302559-C10220C8-5193-409A-9FC5-B18359CF9E54Q36476307-E9D85836-D0FA-4AED-9E7E-22862208E011Q36589502-9E7E7389-D466-4ACE-B805-64BE0868C5E9Q36638223-CFDA49C8-5B70-4E8D-96AF-2D234D6D6D9DQ36729156-F23A6997-DE5C-4F51-90F7-7D1DD9FC9B6EQ36731741-C9688C6E-DBD8-4E50-B3A5-9D510B4080F9Q36897185-08CF542C-18F0-4C7E-86C4-99C36217F09FQ36993382-EDC6551D-B3C7-4E5B-86C6-F65C0178CD02Q37065278-A5BBF28F-7CA1-4FE7-9B56-FD545B6B8148Q37130343-5A4A8974-8961-4475-A78C-3128340062E8Q37339837-704DDA2F-F7FC-4A94-B4B4-88C337DDE4DEQ37428175-8A305B73-D3F0-4DCC-8D85-2942883F4BA8Q37474431-336B5158-3E91-481E-9508-5660F59BEBBFQ37549646-BBE9E64C-1A63-407D-9F39-27EBC5172871Q37588222-BAAABCD2-890C-4794-8805-25818022E830
P2860
Role of lysophosphatidylcholine (LPC) in atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of lysophosphatidylcholine (LPC) in atherosclerosis.
@en
Role of lysophosphatidylcholine
@nl
type
label
Role of lysophosphatidylcholine (LPC) in atherosclerosis.
@en
Role of lysophosphatidylcholine
@nl
prefLabel
Role of lysophosphatidylcholine (LPC) in atherosclerosis.
@en
Role of lysophosphatidylcholine
@nl
P2093
P1476
Role of lysophosphatidylcholine (LPC) in atherosclerosis.
@en
P2093
Katsuo Kamata
Takayuki Matsumoto
Tsuneo Kobayashi
P304
P356
10.2174/092986707782793899
P577
2007-01-01T00:00:00Z